Trials / Not Yet Recruiting
Not Yet RecruitingNCT07209384
Clinical Efficacy of Transarterial Chemoembolization in Elderly Patients With Advanced Unresectable Colorectal Cancer
CLINICAL EFFICACY OF TRANSARTERIAL CHEMOEMBOLIZATION IN ELDERLY PATIENTS WITH ADVANCED UNRESECTABLE COLORECTAL CANCER
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Junpeng Wang · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
We plan to conduct a prospective, two-arm, open-label phase Ⅱ study to evaluate whether transarterial chemoembolization with FOLFOX plus/minus intravenous cetuximab/bevacizumab significantly improves the efficacy and safety compared with systemic FOLFOX therapy plus/minus cetuximab/bevacizumab in elderly patients with advanced unresectable colorectal cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Transarterial chemoembolization | Transarterial chemoembolization with FOLFOX plus/minus intravenous cetuximab/bevacizumab |
Timeline
- Start date
- 2025-10-01
- Primary completion
- 2026-10-01
- Completion
- 2026-10-01
- First posted
- 2025-10-07
- Last updated
- 2025-10-07
Source: ClinicalTrials.gov record NCT07209384. Inclusion in this directory is not an endorsement.